eHealth Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

eHealth wird ein jährliches Gewinn- und Umsatzwachstum von 69.5% bzw. 8.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 87.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 0.7% betragen.

Wichtige Informationen

69.5%

Wachstumsrate der Gewinne

87.9%

EPS-Wachstumsrate

Insurance Gewinnwachstum	11.7%
Wachstumsrate der Einnahmen	8.3%
Zukünftige Eigenkapitalrendite	0.7%
Analystenabdeckung	Low
Zuletzt aktualisiert	11 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

A Piece Of The Puzzle Missing From eHealth, Inc.'s (NASDAQ:EHTH) 31% Share Price Climb

Nov 08

Positive Sentiment Still Eludes eHealth, Inc. (NASDAQ:EHTH) Following 25% Share Price Slump

Aug 30

We Think Some Shareholders May Hesitate To Increase eHealth, Inc.'s (NASDAQ:EHTH) CEO Compensation

Jun 06

eHealth Inc.: Upside Awaits For Patient Investors

May 21

Market Cool On eHealth, Inc.'s (NASDAQ:EHTH) Revenues Pushing Shares 27% Lower

Apr 16

eHealth, Inc. (NASDAQ:EHTH) Just Reported, And Analysts Assigned A US$8.36 Price Target

Mar 01

Time To Worry? Analysts Just Downgraded Their eHealth, Inc. (NASDAQ:EHTH) Outlook

Aug 11

eHealth falls 9% as stock hits 52-week low

Jul 11

eHealth: Wrestling With The Balance Sheet And Costs

Apr 29

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:EHTH - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	569	9	N/A	N/A	1
12/31/2025	516	-42	6	17	3
12/31/2024	486	-61	-26	-13	3
9/30/2024	465	-79	-36	-24	N/A
6/30/2024	471	-72	-31	-19	N/A
3/31/2024	472	-66	-8	3	N/A
12/31/2023	453	-67	-17	-7	N/A
9/30/2023	402	-96	-3	8	N/A
6/30/2023	390	-95	-8	3	N/A
3/31/2023	374	-108	-27	-13	N/A
12/31/2022	405	-119	-42	-27	N/A
9/30/2022	453	-171	-128	-111	N/A
6/30/2022	463	-184	-171	-152	N/A
3/31/2022	509	-162	-178	-158	N/A
12/31/2021	538	-123	-183	-163	N/A
9/30/2021	588	-24	-179	-157	N/A
6/30/2021	618	22	-106	-85	N/A
3/31/2021	611	41	-97	-74	N/A
12/31/2020	583	45	-132	-108	N/A
9/30/2020	591	74	-91	-68	N/A
6/30/2020	567	78	-107	-85	N/A
3/31/2020	544	75	-95	-75	N/A
12/31/2019	506	67	-88	-71	N/A
9/30/2019	339	4	-38	-23	N/A
6/30/2019	310	6	-27	-12	N/A
3/31/2019	277	0	-14	-1	N/A
12/31/2018	251	0	-14	-3	N/A
9/30/2018	200	2	-14	-5	N/A
6/30/2018	190	9	N/A	-13	N/A
3/31/2018	192	20	N/A	-13	N/A
12/31/2017	191	25	N/A	-16	N/A
9/30/2017	151	-19	N/A	-10	N/A
6/30/2017	152	-23	N/A	4	N/A
3/31/2017	155	-22	N/A	8	N/A
12/31/2016	193	0	N/A	4	N/A
9/30/2016	193	0	N/A	10	N/A
6/30/2016	199	9	N/A	19	N/A
3/31/2016	202	15	N/A	30	N/A
12/31/2015	190	-5	N/A	14	N/A
9/30/2015	184	-12	N/A	8	N/A
6/30/2015	187	-14	N/A	8	N/A
3/31/2015	190	-17	N/A	-4	N/A
12/31/2014	180	-16	N/A	2	N/A
9/30/2014	189	1	N/A	12	N/A
6/30/2014	190	0	N/A	10	N/A
3/31/2014	187	-2	N/A	16	N/A
12/31/2013	179	2	N/A	21	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: EHTH wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: EHTH wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: EHTH wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: EHTHDie Einnahmen des Unternehmens (8.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).

Hohe Wachstumseinnahmen: EHTHDie Einnahmen des Unternehmens (8.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: EHTHDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (0.7%).

eHealth Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target decreased by 17% to US$6.67

Consensus EPS estimates fall by 99%, revenue upgraded

Price target decreased by 8.0% to US$7.67

Consensus EPS estimates fall by 31%, revenue upgraded

eHealth, Inc. Reiterate Earnings Guidance for the Full Year Ending December 31, 2024

Price target decreased by 8.2% to US$8.36

Recent updates

Independent Director recently sold US$105k worth of stock

Independent Director notifies of intention to sell stock

A Piece Of The Puzzle Missing From eHealth, Inc.'s (NASDAQ:EHTH) 31% Share Price Climb

Third quarter 2024 earnings: EPS misses analyst expectations

eHealth, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Insufficient new directors

Positive Sentiment Still Eludes eHealth, Inc. (NASDAQ:EHTH) Following 25% Share Price Slump

Price target decreased by 17% to US$6.67

Consensus EPS estimates fall by 99%, revenue upgraded

New minor risk - Share price stability

Price target decreased by 8.0% to US$7.67

eHealth, Inc. Announces Retirement of Fran Soistman as Chief Executive Officer

eHealth, Inc. to Report Q2, 2024 Results on Aug 07, 2024

eHealth, Inc.(NasdaqGS:EHTH) dropped from Russell 3000 Index

We Think Some Shareholders May Hesitate To Increase eHealth, Inc.'s (NASDAQ:EHTH) CEO Compensation

eHealth, Inc. Announces CFO Changes

eHealth Inc.: Upside Awaits For Patient Investors

Consensus EPS estimates fall by 31%, revenue upgraded

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

eHealth, Inc. Reiterate Earnings Guidance for the Full Year Ending December 31, 2024

Market Cool On eHealth, Inc.'s (NASDAQ:EHTH) Revenues Pushing Shares 27% Lower

Price target decreased by 8.2% to US$8.36

New major risk - Revenue and earnings growth

eHealth, Inc. (NASDAQ:EHTH) Just Reported, And Analysts Assigned A US$8.36 Price Target

eHealth, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2024

Full year 2023 earnings released: US$2.37 loss per share (vs US$4.37 loss in FY 2022)

Ehealth, Inc. Unveils "Advisor in the Room" Pilot Program, Bridging the Gap Between Phone and In-Person Support

eHealth, Inc. to Report Q4, 2023 Results on Feb 27, 2024

eHealth: Fairly Valued, But Making Measurable Progress

Sentiment Still Eluding eHealth, Inc. (NASDAQ:EHTH)

New minor risk - Share price stability

Consensus EPS estimates fall by 23%

Price target decreased by 14% to US$9.11

eHealth, Inc. Announces Executive Changes

Consensus EPS estimates fall by 15%, revenue upgraded

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

eHealth, Inc. Provides Earnings Guidance of the Year Ending December 31, 2023

eHealth, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Al Redmer Jr. Joins eHealth's Public Policy Advisory Committee

Independent Chairman of the Board recently bought US$106k worth of stock

Consensus estimates of losses per share improve by 42%

New minor risk - Shareholder dilution

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

eHealth, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2023

eHealth, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Independent Chairman of the Board recently bought US$83k worth of stock

First quarter 2023 earnings released: US$1.01 loss per share (vs US$1.47 loss in 1Q 2022)

Consensus estimates of losses per share improve by 42%

Price target increased by 20% to US$8.30

Full year 2022 earnings released: US$4.37 loss per share (vs US$4.59 loss in FY 2021)

eHealth, Inc. Announces Randall Livingston Not Stand for Re-Election to the Board of Directors

eHealth, Inc. Welcomes Back Lara Sasken as Senior Vice President, Communications

eHealth, Inc. to Report Q4, 2022 Results on Feb 28, 2023

eHealth, Inc. Provides Earning Guidance for Year Ended December 31, 2022

eHealth, Inc. Appoints Ketan Babaria as SVP and Chief Digital Officer

CEO & Director recently bought US$247k worth of stock

High number of new directors

eHealth, Inc. Announces Management Changes

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

eHealth, Inc. Announces Impairment Charges for the Third Quarter Ended September 30, 2022

eHealth, Inc. to Report Q3, 2022 Results on Nov 07, 2022

eHealth, Inc. Appoints Jana Brown as Senior Vice President and Chief People Officer

Now 27% undervalued after recent price drop

eHealth Appoints Michelle Barbeau Chief Marketing Officer

eHealth appoints Michelle Barbeau CMO

Now 28% undervalued after recent price drop

Consensus revenue estimates fall by 15%

Time To Worry? Analysts Just Downgraded Their eHealth, Inc. (NASDAQ:EHTH) Outlook

Price target decreased to US$10.64